Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel potent inhibitors of histone demethylase KDM1A for epigenetic-related cancer therapy

Sep. 18, 2014

ASP-2397, a natural product with potent fungicidal activity

Sep. 18, 2014

Long-term treatment with fingolimod sustains low rates of brain volume loss in LONGTERMS trial

Sep. 18, 2014

Development of non-viral minicircle DNA vectors for phenylketonuria gene therapy

Sep. 18, 2014

RADIANCE results demonstrate RPC-1063 is a promising candidate for relapsing MS

Sep. 17, 2014

Results for the follow-up portion of phase II study evaluating blosozumab

Sep. 17, 2014

Janssen describes novel agents targeting elongation factor 2 for cancer

Sep. 17, 2014

Full results presented for SPARK study of sapropterin in infants with phenylketonuria

Sep. 17, 2014

GlaxoSmithKline presents results for the antibacterial DNA topoisomerase 2 inhibitor

Sep. 17, 2014

First preclinical and clinical data presented for TLR7 agonist GSK-2245035

Sep. 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...